Dimerization capacities of FGF2 purified with or without heparin-affinity chromatography - Wikidata - awgldk - TriplyDB

Dimerization capacities of FGF2 purified with or without heparin-affinity chromatography

Dimerization capacities of FGF2 purified with or without heparin-affinity chromatography

http://www.wikidata.org/entity/Q34317591

about

Fibroblast growth factor 2 dimer with superagonist in vitro activity improves granulation tissue formation during wound healing.

P2860

Q42121550-D69A052C-BB45-4457-B6C2-A1E5EFB63EA1

P2860

Dimerization capacities of FGF2 purified with or without heparin-affinity chromatography

http://www.wikidata.org/entity/Q34317591

description

2014 nî lūn-bûn

@nan

2014 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած

@hyw

2014 թվականի հոտեմբերին հրատարակված գիտական հոդված

@hy

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

name

Dimerization capacities of FGF2 purified with or without heparin-affinity chromatography

@ast

Dimerization capacities of FGF2 purified with or without heparin-affinity chromatography

@en

Dimerization capacities of FGF2 purified with or without heparin-affinity chromatography

@nl

type

label

Dimerization capacities of FGF2 purified with or without heparin-affinity chromatography

@ast

Dimerization capacities of FGF2 purified with or without heparin-affinity chromatography

@en

Dimerization capacities of FGF2 purified with or without heparin-affinity chromatography

@nl

prefLabel

Dimerization capacities of FGF2 purified with or without heparin-affinity chromatography

@ast

Dimerization capacities of FGF2 purified with or without heparin-affinity chromatography

@en

Dimerization capacities of FGF2 purified with or without heparin-affinity chromatography

@nl

P1433

Q34317591-92E3AC77-7336-4CF4-84E2-2E807606B866

P1476

Q34317591-2F81DC1B-F6D3-4827-BEB4-12CF5E28E0A5

P2093

Q34317591-09612745-7B43-4D15-850E-CC862D14BEFA

Q34317591-32619552-BDBE-4B5F-8BC8-3FD67DE126AC

Q34317591-60DB2C61-216B-425B-84D2-79E69123B2F8

Q34317591-7D19716A-77DD-497D-A030-87C8119D5677

Q34317591-7E48237A-8EE6-4822-BD86-E52A2CABDEE6

Q34317591-8694427C-1EB3-4E79-A239-D3179E56FAD4

Q34317591-BEDD10A4-A142-43CC-B9F5-6C74009BAFC0

Q34317591-C2EE5726-35CF-480E-BF9F-CE0416AABEBB

P2860

Q34317591-047DE621-EC79-47E7-AFC0-B1C746C5CB4B

Q34317591-15806D1F-C320-423C-B151-422D984DD478

Q34317591-1FCC1C98-BD40-46ED-9267-D837DE5B5B31

Q34317591-2822435D-D136-4F7B-90C5-3D90527FA8E8

Q34317591-342E6DDD-0AEC-40AF-92DC-040D0296E86F

Q34317591-3DD6BC1A-2903-4734-B4BA-D56D05092710

Q34317591-48FBC282-A461-4E1A-92FD-0A86AD6FEE7A

Q34317591-6423F4D6-CD30-467C-9D5C-893052D1DFA1

Q34317591-6F719233-2425-45B3-A097-5F9AA88E307C

Q34317591-711E80DE-9A78-4C9B-809F-A932BDEA4523

P304

Q34317591-B13B6A31-90AD-4276-BDD1-AE777353720E

P31

Q34317591-FBFC8324-607E-4EE7-B4E1-83EB5DF76CF8

P356

Q34317591-60413EE9-955F-4682-BDE8-12B0D460F8DC

P407

Q34317591-A87BD797-FD16-4B91-9F84-8AE0D2227752

P433

Q34317591-2C1F4520-82EB-4A33-AE72-C28B5932AED6

P478

Q34317591-3C317A13-F2B0-4AC6-9645-C0E08604A4C5

P50

Q34317591-BB4787B4-9285-4C8C-91A9-7D1A9E468849

P577

Q34317591-18C91D64-820D-40AF-94C4-19545EEBE65A

P5875

Q34317591-23DD656B-97CF-406E-9214-9D7AB7A7D940

P698

Q34317591-9159FD23-26E1-42F3-8390-6908FA904A60

P932

Q34317591-3FCCBA37-68EE-4930-A259-11AD948BFE59

P356

JOURNAL.PONE.0110055

P1433

P1476

Dimerization capacities of FGF2 purified with or without heparin-affinity chromatography

@en

P2093

Andreas Bikfalvi

http://www.w3.org/2001/XMLSchema#string

Elisabetta Moroni

http://www.w3.org/2001/XMLSchema#string

Eric Chevet

http://www.w3.org/2001/XMLSchema#string

Géraldine Miquel

http://www.w3.org/2001/XMLSchema#string

Liang-Yuan Chiu

http://www.w3.org/2001/XMLSchema#string

Natalia Platonova

http://www.w3.org/2001/XMLSchema#string

Said Taouji

http://www.w3.org/2001/XMLSchema#string

Shih-Che Sue

http://www.w3.org/2001/XMLSchema#string

P2860

Crystal structure of the VHS and FYVE tandem domains of Hrs, a protein involved in membrane trafficking and signal transduction

Molecular mechanism for dimerization to regulate the catalytic activity of human cytomegalovirus protease

Homodimerization Controls the Fibroblast Growth Factor 9 Subfamily's Receptor Binding and Heparan Sulfate-Dependent Diffusion in the Extracellular Matrix

High-resolution solution structure of basic fibroblast growth factor determined by multidimensional heteronuclear magnetic resonance spectroscopy

Fibroblast growth factor receptors cooperate to regulate neural progenitor properties in the developing midbrain and hindbrain

Fibroblast growth factors: from molecular evolution to roles in development, metabolism and disease.

Structural basis for fibroblast growth factor receptor activation.

BMP-2 differentially modulates FGF-2 isoform effects in osteoblasts from newborn transgenic mice

FGF9 monomer-dimer equilibrium regulates extracellular matrix affinity and tissue diffusion.

Evidence that heparin saccharides promote FGF2 mitogenesis through two distinct mechanisms.

P304

e110055

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1371/JOURNAL.PONE.0110055

http://www.w3.org/2001/XMLSchema#string

P407

P433

10

http://www.w3.org/2001/XMLSchema#string

P478

9

http://www.w3.org/2001/XMLSchema#string

P50

Giorgio Colombo

P577

2014-10-09T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

266682424

http://www.w3.org/2001/XMLSchema#string

P698

25299071

http://www.w3.org/2001/XMLSchema#string

P932

4192534

http://www.w3.org/2001/XMLSchema#string